# Metsola Ventures

> Metsola Ventures is a VC fund in Espoo backing Medical, mHealth and Health Care. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Espoo, Finland
- Total investments: 2
- Last investment: Apr 2018
- Lead investor: 0%
- Last updated: Aug 2026

Metsola Ventures is a VC fund in Espoo focused on Medical and mHealth. Metsola Ventures

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.2M–$4.8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 100% |
| mHealth | 1 | 50% |
| Health Care | 1 | 50% |
| Biotechnology | 1 | 50% |
| Medical Device | 1 | 50% |

7 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kaiku Health | Kaiku Health is a digital health company with a mission to improve quality of life through health data science. We have built an intelligent digital platform for monitoring patient-reported outcomes in several therapy areas, such as cancer care, fertility treatments and preventive health care. Its unique algorithms enable early interventions andpersonalized patient support. Currently over 30 European hospitals and clinics are using our platform to better monitor their patients, reducing manual work and allowing prioritization of clinical actions. This along with the capture and analysis of real-world data paves way for more personalized and effective care of each patient. The company, founded in 2012 by five software developers deeply passionate about health care technology, has now grown to team of 20+ dedicated employees. The company is backed by Reaktor Ventures, along with other venture capital funds and private investors, and is supported by Tekes – the Finnish Funding Agency for Innovation. | $4.8M | Series A | Apr 05, 2018 |  |
| Synoste Oy | Synoste is a Finnish startup company that develops and will sell novel patient friendly medical solutions for treatment of skeletal deformities. The first target is a better device for the well known, but complication prone limb lengthening procedure, which is still extremely uncomfortable for the patient. Synoste utilizes smart materials andintroduces a less painful and precisely controllable treatment device that lowers the complication rate and enables faster recovery to normal life. | $2.2M | Series A | May 06, 2015 |  |

2 of 2 investments shown.

## Co-investors
- [Athensmed](https://shizune.co/investors/profile/athensmed) — VC Fund, 1 deal together
- [Debiopharm Innovation Fund](https://shizune.co/investors/profile/debiopharm-innovation-fund) — VC Fund, 1 deal together
- [Finnvera Venture Capital](https://shizune.co/investors/profile/finnvera-venture-capital) — VC Fund, 1 deal together
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund, 1 deal together
- [Prodeko Ventures](https://shizune.co/investors/profile/prodeko-ventures) — VC Fund, 1 deal together
- [Reaktor Ventures](https://shizune.co/investors/profile/reaktor-polte) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund
- [Lifeline Ventures](https://shizune.co/investors/profile/lifeline-ventures) — VC Fund
- [Tesi](https://shizune.co/investors/profile/tesi) — VC Fund

## Featured in investor lists
- [Medical VC Funds in Finland](https://shizune.co/investors/medical-vc-funds-finland)
- [Health Care Investors in Finland](https://shizune.co/investors/health-care-investors-finland)
- [Health Care VC Funds in Finland](https://shizune.co/investors/health-care-vc-funds-finland)
- [Medical Device VC Funds in Finland](https://shizune.co/investors/medical-device-vc-funds-finland)
- [Mobile Investors in Finland](https://shizune.co/investors/mobile-investors-finland)
- [Biotechnology Investors in Finland](https://shizune.co/investors/biotechnology-investors-finland)

## FAQ

### What does Metsola Ventures invest in?

Metsola Ventures invests primarily in Medical, mHealth and Health Care startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Metsola Ventures's check size?

Metsola Ventures typically joins rounds of $2.2M–$4.8M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Metsola Ventures participates in.

### When did Metsola Ventures last invest?

The most recent investment recorded for Metsola Ventures closed in Apr 2018. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co